2nd Quarter - Report
RED+BLUE STRATEGIES for HOSPIRA
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Working to ensure that issues related to coding and reimbursement are discussed and addressed to ensure a smooth start to the coverage of biosimilar medications as they enter into the United States' prescription drug market this year.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.